Reply to: "Stereotactic body radiation therapy vs. radiofrequency ablation for HCC: More questions than answers"

J Hepatol. 2020 Oct;73(4):973-974. doi: 10.1016/j.jhep.2020.05.031. Epub 2020 Jul 6.

Authors

Nalee Kim¹, Jinsil Seong²

Affiliations

¹ Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: rodr.naleekim@gmail.com.
² Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: jsseong@yuhs.ac.

PMID: 32646619
DOI: 10.1016/j.jhep.2020.05.031

No abstract available

Publication types

Letter
Comment

MeSH terms

Asian People
Carcinoma, Hepatocellular* / radiotherapy
Carcinoma, Hepatocellular* / surgery
Humans
Liver Neoplasms* / surgery
Radiofrequency Ablation*
Radiosurgery*